Previous Page  3 / 14 Next Page
Information
Show Menu
Previous Page 3 / 14 Next Page
Page Background

Volume 7, Issue 1 (Suppl)

J Clin Exp Pathol

ISSN: 2161-0681 JCEP, an open access journal

Pediatric Pathology & Laboratory Medicine 2017

March 15-16, 2017

Page 27

conference

series

.com

March 15-16, 2017 London, UK

12

th

International Conference on

Pediatric Pathology & Laboratory Medicine

Electron Paramagnetic Resonance (EPR) spectroscopy for diagnosis and characterization of

mitochondrial dysfunction and diseases

M

itochondrial disease (MD) presents with a wide range of clinical, pathological and biochemical outcomes and is

consequently very difficult to diagnose conclusively. EPR is a magnetic resonance technique that detects and characterizes

unpaired electrons that are present in transition metal ions in certain oxidation states {e.g. Fe

(III)

, Cu

(II)

and Mn

(II)

}, clusters

(e.g., [2Fe2S]

+

red

, [3Fe4S]

+

ox

, [4Fe4S]

+

red

) and free radicals (e.g., UQ

•−

, FADH•). The mitochondrial respiratory chain complexes

I-IV contain 23 potentially paramagnetic centers that exhibit distinct EPR signals depending on their redox potentials, the

availability of electrons, the catalytic competence of each of the enzymatic complexes and the integrity of the electron transport

chain (ETC). In addition, EPR signals may be observed fromUQ

•−

, and from the [3Fe4S]

+

cluster of m-aconitase that arises due

to oxidative stress. Key factors thought to be involved in the symptoms and pathology of MD is lowered ATP production and the

production of toxic reactive oxygen species (ROS). Either or both of these can occur when electron transfer is impeded due to

lowered expression, lowered activity, or structural alteration of ETC complexes, or compromised ingress or egress of reducing

equivalents. EPR of rapidly-frozen fresh biopsy tissue is uniquely able to provide a snapshot of the electron distribution among

the redox centers in the functioning mitochondrial ETC against a background of other biochemical and pathological assays.

We recently described the first application of this methodology to a rat model of MD and will here describe progress toward

translation of the approach for diagnosis and differentiation of MDs in children.

Biography

Brian Bennett has completed his BA and MA in Natural Sciences from the University of Cambridge and DPhil in Biochemistry from the University of Sussex. Currently, he

is a Chair and Distinguished Professor of Physics at Marquette University, USA.

brian.bennett@marquette.edu

Brian Bennett

Marquette University, USA

Brian Bennett, J Clin Exp Pathol 2017, 7:1 (Suppl)

http://dx.doi.org/10.4172/2161-0681.C1.030